Chronic
neuroinflammation plays an important role in the development and maintenance of
neuropathic pain. The compound
flexibilide, which can be obtained from cultured soft coral, possesses anti-inflammatory and
analgesic effects in the rat
carrageenan peripheral
inflammation model. In the present study, we investigated the antinociceptive properties of
flexibilide in the rat chronic constriction injury (CCI) model of
neuropathic pain. First, we found that a single intrathecal (i.t.) administration of
flexibilide significantly attenuated CCI-induced
thermal hyperalgesia at 14 days after surgery. Second, i.t. administration of 10-μg
flexibilide twice daily was able to prevent the development of
thermal hyperalgesia and weight-bearing deficits in CCI rats. Third, i.t.
flexibilide significantly inhibited CCI-induced activation of microglia and astrocytes, as well as the upregulated proinflammatory
enzyme,
inducible nitric oxide synthase, in the ipsilateral spinal dorsal horn. Furthermore,
flexibilide attenuated the CCI-induced downregulation of spinal transforming growth factor-β1 (TGF-β1) at 14 days after surgery. Finally, i.t.
SB431542, a selective inhibitor of TGF-β type I receptor, blocked the
analgesic effects of
flexibilide in CCI rats. Our results suggest that
flexibilide may serve as a therapeutic agent for
neuropathic pain. In addition, spinal TGF-β1 may be involved in the anti-neuroinflammatory and
analgesic effects of
flexibilide.